COVID-19 antiviral pill, developed by Merck and Ridgeback Biotherapeutics.On Friday, COVID-19 vaccine maker Pfizer unveiled promising results on their experimental pill, claiming that it could cut rates of hospitalization and death from the virus by nearly 90 per cent.Public health experts have described the implementation of the anti-viral pills as potentially game-changing in the fight against the pandemic, citing both their effectiveness in preventing severe disease and death as well as their low cost to produce.
New Pfizer COVID-19 pill reduces hospital, death risk by 90%, company says Here’s what you need to know about the anti-viral COVID-19 pills.The antiviral drugs have intrigued health experts and epidemiologists in how they.